Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Amarin's SNDA For Anchor WILL BE APPROVED ON TIME, PERIOD

|Includes:Amarin Corporation PLC (AMRN)

AF is a lower than the piece of dirt caught in my shoe treads. Anchor will be approved for mixed. lip and there is nothing he can do about it. New flash AF, mixed lip indication is NOT for reducing cardio events, its for lower trigs, and that is what it does, period. FDA will approve the drug for its APPLIED FOR INDICATION.

And, if we are throwing out predictions, mine is that Reduce It will be successful for reducing cardio events too.

Stocks: AMRN